Parkway Cancer Center provides personalized care and cutting-edge medical advancements that enhance colorectal cancer treatment, improving survival rates and quality of life.
Cancer treatment is never one-size-fits-all, especially for colorectal cancer, where each patient’s case is unique. Advances in medical technology and specialized cancer care allow doctors to develop more effective, less invasive, and highly personalized treatment strategies. Colorectal cancer remains one of the most prevalent cancers worldwide, requiring innovative approaches to diagnosis, staging, and treatment.
Parkway Cancer Center integrates cutting-edge medical advancements, such as targeted therapies and immunotherapy, to enhance colorectal cancer treatment. These precision-based treatments focus on the cancer’s molecular profile, leading to more effective results with fewer side effects. By continuously adopting innovative techniques, Parkway Cancer Center is improving patient outcomes and boosting survival rates for those battling colorectal cancer.
Significant advancements in colorectal cancer treatment have provided effective options, particularly for advanced cases. The most suitable approach depends on the tumor type, location, and patient characteristics. Treatments include local therapies for early-stage cancer and systemic treatments that circulate throughout the body to target cancer cells.
Surgical removal of the tumor and nearby lymph nodes is a common approach, performed through either laparoscopy (minimally invasive) or laparotomy (open surgery). There are also treatments that use medications to reach cancer cells throughout the body such as chemotherapy, targeted therapy, and immunotherapy.
These systemic advanced treatments have been proven factors in increasing survival rates of colon cancer patients. For instance, in a clinical trial in June last year by Cercek, involving patients with a particular genetic mutation, an immunotherapy approach led to all 41 participants becoming cancer-free without the need for additional treatment. This outcome is particularly impactful for younger patients seeking to avoid permanent side effects associated with traditional treatments.
For colon cancer treatment, Parkway Cancer Centre provides advanced medicines such as immunotherapy and targeted therapies, demonstrating encouraging results in severe colon cancer. These treatments are tailored to the cancer’s molecular profile, providing more effective treatment options and fewer adverse effects.
For prostate cancer treatment, radiation therapy is frequently used to target cancer cells while minimizing tissue harm precisely. Advanced imaging technologies, such as MRI and PET scans, are commonly used to guide treatment and track cancer growth. Furthermore, genetic testing allows medical professionals to find mutations in cancer cells that can be targeted with specific medications, enhancing treatment outcomes.
Early detection remains crucial in improving survival rates. When colorectal cancer is diagnosed at an early stage, the five-year relative survival rate is about 90 percent. By incorporating these medical advancements and emphasizing early detection, Parkway Cancer Center aims to enhance treatment efficacy, reduce side effects, and ultimately improve the quality of life for colorectal cancer patients.
Importance of post-treatment care
Fighting cancer does not end with treatment. Post-treatment care is critical for patients to recover and preserve their quality of life. The specialist care continues after the active treatment phase is over. Oncology nurses, dieticians, physiotherapists, and counselors at Parkway Cancer Centre offer ongoing support through rehabilitation programs, dietary counseling, and mental health services. This comprehensive strategy assists patients in managing side effects, maintaining their physical health, and coping with the emotional problems of cancer recovery. Furthermore, regular follow-up meetings with specialists ensure that any cancer recurrence is recognized early, giving patients the best chance of success if re-treatment is required.